| # | Fund | Position value | Shares | Last move | As of |
|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | $115.3M | 1.83M | New | Q1 2026 |
| 2 | VIKING GLOBAL INVESTORS LP | $106.8M | 1.69M | New | Q1 2026 |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | $44.2M | 699.6K | New | Q1 2026 |
| 4 | STATE STREET CORP | $4.7M | 74.4K | New | Q1 2026 |
No Form 4 insider transactions on file yet.
| Company | Co-held by | Combined value |
|---|---|---|
| Cytokinetics IncCYTK | 9 funds | $675.0M |
| Microsoft CorpMSFT | 8 funds | $115.6B |
| Tesla IncTSLA | 8 funds | $44.6B |
| Bridgebio Pharma IncBBIO | 8 funds | $1.6B |
| Insmed IncINSM | 8 funds | $1.5B |
| United Therapeutics CorpUTHR | 8 funds | $1.5B |
| Biogen IncBIIB | 8 funds | $1.4B |
| Mirum Pharmaceuticals IncMIRM | 8 funds | $415.4M |
| Tango Therapeutics IncTNGX | 8 funds | $374.3M |
| Oric Pharmaceuticals IncORIC | 8 funds | $231.6M |
| Trevi Therapeutics IncTRVI | 8 funds | $171.2M |
| NVIDIA CorpNVDA | 7 funds | $177.2B |
Ranked by how many of MANE's institutional holders also hold each name — a cross-fund conviction signal. Via the MCP server (ticker.co_held).
No filings captured for this ticker in the live stream yet.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for MANE. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes. Every panel above is one call to the Arkolith API & MCP server.